Intriguingly, recent studies have suggested that COX-2 is frequently aberrantly expressed in various cancers and promotes tumorigenesis in breast cancer, prostate cancer, lung cancer, and especially in CRC [23, 24]. This evidence concerns the gene PTGS2 and lung carcinoma.